Amprion is the global leader in advancing the diagnosis of neurodegenerative disorders through the development and application of Seed Amplification Assays (SAA). Our technology empowers precision medicine by enabling early, accurate detection of misfolded proteins associated with diseases like Alzheimer’s, Parkinson’s, and Lewy body dementia.

Historically, diagnosis and treatment of neurodegenerative diseases have been symptom-driven, often resulting in misdiagnosis and delayed care. Many patients endure a “diagnostic odyssey,” seeking answers that are often not confirmed until autopsy. With limited tools available, physicians have historically had to rely on their best judgment rather than definitive biological evidence.

Amprion’s SAAmplify™ platform changes that paradigm. By enabling highly sensitive, early detection of disease-causing proteins, we provide critical biological insights that support earlier intervention, enhance clinical trial recruitment, and accelerate the discovery of disease-modifying therapies. Our mission is to help end the global burden of Alzheimer’s, Parkinson’s, and other neurodegenerative disorders through groundbreaking diagnostic solutions.

Position Summary:

The Diagnostic Service Consultant plays a pivotal role in expanding access to Amprion’s breakthrough diagnostic technology by partnering with healthcare providers, institutions, and key opinion leaders (KOLs). The consultant is responsible for driving adoption of SAAmplify, fostering strong customer relationships, and contributing to the growth and success of Amprion’s commercial organization.

This is an exciting opportunity for a results-driven individual passionate about transforming the way neurodegenerative diseases are diagnosed and treated.

Key Responsibilities:

• Strategically execute territory business plans to achieve and exceed revenue and volume goals.
• Support seamless workflows for new and existing accounts to drive consistent utilization of SAAmplify testing.
• Develop a deep understanding of the clinical utility of SAAmplify and its impact across the neurodegenerative disease landscape.
• Establish and maintain strong, influential relationships with neurologists, movement disorder specialists, cognitive disorder clinics, academic centers, and other key stakeholders.
• Identify, engage, and collaborate with key opinion leaders (KOLs) to build advocacy and drive clinical adoption.
• Maintain accurate records of account activity and opportunity pipelines through regular Salesforce.com updates.
• Stay current on competitive products, emerging therapeutic options, clinical research developments, and changes in the diagnostics landscape.
• Represent Amprion at regional and national industry conferences, symposia, and events to build brand awareness and generate leads.
• Contribute positively to the broader commercial team by sharing best practices, market intelligence, and supporting team initiatives.

Qualifications:

• Minimum 5 years of successful sales experience in diagnostics, medical devices, life sciences, or a related healthcare market.
• Demonstrated success managing a territory with a mix of institutional facilities, specialty clinics, and independent practices.
• Strong understanding of diagnostic markets, especially within neurology or CNS-related specialties, is highly preferred.
• Bachelor’s degree in life sciences, biology, business, marketing, or a related field is strongly preferred.
• Proficiency with Salesforce.com CRM platform and Microsoft Office Suite (Excel, PowerPoint, Word, Outlook).
• Excellent communication, organizational, and problem-solving skills with the ability to navigate complex sales processes.
• Self-motivated, entrepreneurial spirit with a growth mindset and the ability to work independently.

Compensation and Benefits:

• Base Salary Range: $110,000 – $130,000
• On-Target Earnings (OTE): $160,000 – $180,000
• Benefits: Comprehensive medical, dental, and vision coverage; 401(k) plan
• Equity Potential: Opportunity for stock options
• Additional: Professional development opportunities and the chance to be part of a pioneering organization advancing the future of neurodegenerative disease diagnosis.